Objective—
MicroRNAs play a role in atherosclerosis-related diseases, such as cerebrovascular or cardiovascular disease. However, the effect of
miR-146a
,
miR-149
,
miR-196a2
, and
miR-499
polymorphisms on stroke and silent brain infarction (SBI) susceptibility has not been reported.
Methods and Results—
Using polymerase chain reaction-amplified DNA, microRNA polymorphisms were analyzed in 678 patients with ischemic stroke, 373 patients with SBI, and 553 control subjects. The
miR-146a
C>G polymorphism and
miR-146a
G/
-149
T/
-196a2
C/
-499
G allele combination was significantly associated with ischemic stroke prevalence. For SBI prevalence, there were no statistically significant genetic markers. However, some allele combinations were associated with increased SBI incidence (C-T-C-G and G-T-T-A of
miR-146a
/
-149
/
-196a2
/
-499
). In subgroup analyses,
miR-146a
C>G increased stroke risk in female, normotensive, and nondiabetic groups. There were significant combined effects between microRNA polymorphisms and homocysteine/folate levels on ischemic stroke and SBI prevalence.
Conclusion—
The
miR-146a
G allele and
miR-146a
G/
-149
T/
-196a2
C/
-499
G allele combination were associated with ischemic stroke pathogenesis. The combined effects between microRNA polymorphisms and homocysteine/folate levels may contribute to stroke and SBI prevalence.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.